Twist Bioscience Corporation

DB:0ME Stock Report

Market Cap: €2.6b

Twist Bioscience Management

Management criteria checks 2/4

Twist Bioscience's CEO is Emily Leproust, appointed in Apr 2013, has a tenure of 11.58 years. total yearly compensation is $8.00M, comprised of 8.6% salary and 91.4% bonuses, including company stock and options. directly owns 0.47% of the company’s shares, worth €12.41M. The average tenure of the management team and the board of directors is 2.6 years and 8 years respectively.

Key information

Emily Leproust

Chief executive officer

US$8.0m

Total compensation

CEO salary percentage8.6%
CEO tenure11.6yrs
CEO ownership0.5%
Management average tenure2.6yrs
Board average tenure8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Emily Leproust's remuneration changed compared to Twist Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$209m

Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$192m

Dec 31 2023n/an/a

-US$206m

Sep 30 2023US$8mUS$685k

-US$205m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$213m

Dec 31 2022n/an/a

-US$214m

Sep 30 2022US$6mUS$665k

-US$218m

Jun 30 2022n/an/a

-US$208m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021n/an/a

-US$165m

Sep 30 2021US$1mUS$590k

-US$152m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020n/an/a

-US$117m

Sep 30 2020US$7mUS$519k

-US$140m

Jun 30 2020n/an/a

-US$147m

Mar 31 2020n/an/a

-US$147m

Dec 31 2019n/an/a

-US$141m

Sep 30 2019US$8mUS$477k

-US$108m

Jun 30 2019n/an/a

-US$96m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018n/an/a

-US$77m

Sep 30 2018US$525kUS$362k

-US$71m

Compensation vs Market: Emily's total compensation ($USD8.00M) is above average for companies of similar size in the German market ($USD1.92M).

Compensation vs Earnings: Emily's compensation has increased whilst the company is unprofitable.

CEO

Emily Leproust (51 yo)

11.6yrs

Tenure

US$7,998,637

Compensation

Dr. Emily Marine Leproust, Ph.D. serves as Independent Director at CM Life Sciences, Inc. since September 2, 2020. She serves as an Independent Director at GeneDx Holdings Corp. (formerly known as Sema4 Ho...

Leadership Team

NamePositionTenureCompensationOwnership
Emily Leproust
Co-Founder11.6yrsUS$8.00m0.47%
€ 12.4m
Patrick Finn
President & COO2.1yrsUS$5.23m0.13%
€ 3.4m
Paula Green
Senior Vice President of Human Resources8.7yrsUS$2.49m0.060%
€ 1.6m
William Banyai
Senior VP of Advanced Development4.8yrsUS$2.82m0.44%
€ 11.4m
Adam Laponis
Chief Financial Officerless than a yearno data0.012%
€ 306.8k
Robert Werner
VP & Chief Accounting Officer1.5yrsno data0.016%
€ 411.7k
Siyuan Chen
Chief Technology Officer3.8yrsno datano data
Michael Fero
Chief Information Officerless than a yearno datano data
Dennis Cho
Senior VP3.2yrsUS$1.96m0.067%
€ 1.8m
Nicole Moreno
Senior Vice President of Sales & Supportno datano datano data
Angela Bitting
Chief ESG Officer & Senior VP of Corporate Affairs3.8yrsno datano data
Mark Buck
Senior Vice President of Operations1.1yrsno datano data

2.6yrs

Average Tenure

52yo

Average Age

Experienced Management: 0ME's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Emily Leproust
Co-Founder11.6yrsUS$8.00m0.47%
€ 12.4m
William Banyai
Senior VP of Advanced Development11.6yrsUS$2.82m0.44%
€ 11.4m
Keith Crandell
Independent Director11.1yrsUS$272.49k0.16%
€ 4.2m
Robert Chess
Lead Independent Director10.3yrsUS$303.98k0.11%
€ 2.8m
Nelson Chan
Independent Director5.5yrsUS$284.99k0.030%
€ 791.3k
Robert Ragusa
Independent Director8yrsUS$271.34k0.023%
€ 602.3k
Jan Johannessen
Independent Director6.1yrsUS$284.99k0.020%
€ 514.5k
Melissa Starovasnik
Independent Director3.3yrsUS$276.61k0.018%
€ 482.1k
Xiaoying Mai
Independent Director6.3yrsUS$269.99k0.043%
€ 1.1m

8.0yrs

Average Tenure

64yo

Average Age

Experienced Board: 0ME's board of directors are considered experienced (8 years average tenure).